Hospitals | April 14, 2026
Shalby Hospitals gets 5-year kidney transplant approval for Ahmedabad Krishna Unit
The license is valid for five years, effective from April 9, 2026
The license is valid for five years, effective from April 9, 2026
The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker
The study is a global, randomized, double-blind, placebo-controlled trial testing GLM101 for phosphomannomutase 2 congenital disorder of glycosylation
Punya Salila Srivastava commends sanitation, waste management and infection control measures, while inaugurating a new G+9 undergraduate girls’ hostel
Nature Medicine study delivers strongest real-world evidence yet for India’s indigenous rotavirus vaccine under UIP
For the biopharma industry, the study strengthens the case for balancing immune-cell engagement with tolerability in antibody discovery platforms
The results were consistent across both the 10 mg and 40 mg treatment arms
The data will be presented at the 2026 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress in Munich, April 17-21
Move aligns global biologics identity under the Biocon Biologics brand
Safety was equally impressive. ENV-294 was well tolerated
Subscribe To Our Newsletter & Stay Updated
